Introduction
Sj€ ogren's syndrome (SS) is a systemic autoimmune disease of unknown aetiology characterized by chronic inflammation and damage of salivary glands and lacrimal glands, leading to sicca symptoms such as dry mouth and dry eyes as a result of reduced secretion of saliva and tears [1] . The pathological findings in exocrine glands of patients with SS include lymphocytic infiltration and glandular destruction [2] .
There have been some reports which show DNA microarray analyses in labial salivary glands (LSGs) of SS and healthy controls [3, 4] . They identified the genes associated with mononuclear infiltration, such as immunoglobulins, human leucocyte antigen, T cell receptors and interferon (IFN)-inducible genes [3, 4] . However, as the control subjects in these studies were healthy individuals whose LSGs are free of inflammation, it is possible that the results reflected non-specific gene expression due to inflammatory cell infiltration.
Similar to SS, immunoglobulin (Ig)G4-related diseases (IgG4-RD) are often associated with sialadenitis or dacryoadenitis. Although the aetiology is not clear, there is little evidence for the involvement of autoantibodies in IgG4-RD compared with SS. Clinically, the secretion of saliva is often spared in IgG4-RD compared with SS. Furthermore, IgG4-related sialadenitis and dacryoadenitis, socalled IgG4-related Mikulicz's disease, but not SS, show good response to corticosteroid treatment [5] . Conversely, the pathology of IgG4-related sialadenitis is characterized by the infiltration of IgG4-positive plasma cells accompanied by CD4
1 T cells [6] . Therefore, as the genes expressed specifically in SS could be possibly identified by comparing gene expression in LSGs of SS with those of IgG4-RD, which also show inflammation and lymphocyte infiltration, in this study we conducted cDNA microarray analysis in LSGs of SS and IgG4-RD.
We compared previously the LSG gene expression profiles of IgG4-RD and SS [7] . The results showed differences in the gene expression patterns and differentially expressed genes (DEGs) between the two conditions and, accordingly, we then analysed those in LSGs of IgG4-RD [7] . In the present study, we focused on the gene expression in LSGs of SS and performed analyses of genes that are specific to the pathology of SS.
In SS, emerging roles of T helper type 17 (Th17) in the pathogenesis were suggested recently in some studies [8] [9] [10] [11] [12] . In patients with SS, the predominant interleukin (IL)-17 expression in CD4
1 T cells within lymphocytic infiltrates was detected in the salivary glands [8, 9] . Other studies also showed a close relationship between IL-17 or Th17 cells and disease onset or progression [10] [11] [12] . Therefore, we also focused on the functional association of the validated genes with Th17 cells in SS.
Previous studies also indicated that among the Th17-related molecules, nuclear receptor subfamily 4, group A and member 2 (NR4A2), is an important molecule that promotes Th17 differentiation via the regulation of IL-21 production, which enables the expression of IL-23 receptor [13] . Furthermore, studies on an animal model of experimental autoimmune encephalomyelitis (EAE) showed that in-vivo injection of NR4A2 siRNA specifically inhibited IL-17 production in CD4
1 T cells, suggesting that NR4A2 plays a critical role in the pathogenesis of EAE through the promotion of Th17 differentiation [13, 14] . In addition, nuclear translocation of NR4A2 was reported as an important mechanism of its transcriptional activation [15] . The other activation mechanisms, such as co-operative transcriptional activation and small ubiquitin-like modifier (SUMO)ylation of NR4A2, were also indicated [16, 17] .
In summary, the present study was designed to examine further the pathophysiological mechanism of SS. First, we compared the results of cDNA microarray analysis and gene expression levels in LSGs of SS and IgG4-RD. Secondly, we examined the functional association between the validated genes in Th17 cells and SS. Thirdly, we determined the roles of NR4A2 in the pathogenesis of SS in the context of Th17 differentiation.
Methods

Patients and healthy subjects
This study was carried out in accordance with the Declaration of Helsinki. Approval for this study was obtained from our local ethics committees (approval number: H24-164) and a signed informed consent was obtained from each subject prior to the inclusion in this study. All patients with SS satisfied both the Japanese Ministry of Health criteria for the diagnosis of SS (1999) [18] and American College of Rheumatology classification criteria for SS (2012) [19] . In contrast, all patients with IgG4-RD satisfied the diagnostic criteria for IgG4-RD proposed in 2011 by the All Japan IgG4 team [20] . All patients and healthy controls (HCs) were naive to immunosuppressive therapy. Healthy subjects matched for sex and age were recruited as controls in comparison with SS patients. All samples were collected after obtaining informed consent.
cDNA microarray analysis
As we reported previously, the gene expression was analysed by cDNA microarray using the GeneChip Human Genome U133 Plus version 2.0 array (Affymetrix) and LSGs of SS patients (n 5 5, all females), IgG4-RD patients (n 5 5, all females) and HCs (n 5 3, all females). The reason that we selected only females was that an overwhelming majority of SS patients are female [21] . The methods of isolation and purification of total RNA for the cDNA microarray analysis were described in detail in our previous report [7] . All microarray data were minimum information about a microarray-compliant experiment (MIAME) and have been deposited in a MIAME-compliant database; the National Center for Biotechnology Information Gene Expression Omnibus (GEO Series Accession number: GSE40568), as detailed on the Microarray and Gene Expression Data (MGED) Society website. After the obtained microarray data were normalized by forward and all subsets regression for model selection (FARMS) algorithm, the DEGs between SS and IgG4-RD were identified in pairwise comparisons [false discovery rate (FDR) < 0Á05] by the rank products method. We focused especially on the up-regulated DEGs in SS in the present study.
Validation by quantitative polymerase chain reaction (qPCR) qPCR was also conducted for validation of up-regulated DEGs in SS identified by cDNA microarray analysis. The candidate DEGs for the validation were selected based on the following conditions: (1) rank > 150, 2) FDR < 0Á0001, (3) logarithm of fold change (FC) > 1Á00, (4) small dispersion among the SS subjects and (5) their association with T cell activation or regulation had been reported previously. Total RNA was extracted from LSGs of six HCs, 15 patients with SS and 12 patients with IgG4-RD (different from the subjects who provided samples for cDNA microarray analysis). After extraction of total RNA using the ISOGEN (Nippon gene) method, cDNA was synthesized using a cDNA synthesis kit (Takara Bio, Shiga, Japan). The mRNA expression level of the target genes was cDNA microarray identifies NR4A2 in SS examined by qPCR using the 7500 real-time (RT)-PCR system (Applied Biosystems, Foster City, CA, USA) with the SYBR Green PCR kit (Takara Bio). Predesigned primers specific for the targeted genes (Takara Bio) were used for qPCR. The human-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was also examined as an internal control.
Immunofluorescence staining for protein production
Next, we focused on the validated gene with significant difference in LSGs mRNA expression between SS and IgG4-RD patients. Protein production of the gene in LSGs of SS and IgG4-RD patients was examined by indirect immunofluorescence assay. Cryostat sections of LSGs of SS and IgG4-RD patients naive to immunosuppressive therapy were washed five times for 5 min each in phosphatebuffered saline (PBS) with 0Á05% Tween 20, followed by 30-min incubation with blocking solution, 5% bovine serum albumin in PBS. Then the sections were incubated with primary antibodies to the targeted protein [rabbit NR4A2 antibodies (Santa Cruz Technology, Santa Cruz, CA, USA); sc-991, used at 2 lg/ml] overnight at 48C. The sections were subsequently washed five times for 5 min each in PBS with 0Á05% Tween 20, then incubated with fluorescently labelled secondary antibodies [goat anti-rabbit IgG antibody (Invitrogen, Carlsbad, CA, USA; A-11034) diluted to 20 lg/ml as a final concentration] for 30 min at room temperature. The sections were washed again five times in PBS with 0Á05% Tween 20 for 5 min each. The sections were counterstained for CD3, CD4 and IL-17 using primary antibodies (BioLegend, San Diego, CA, USA; Biolegend, 317302, BioLegend, 317402; Santa Cruz; sc-7927, respectively) and fluorescently labelled secondary antibody for CD3 and CD4 (Invitrogen; A-11030) or Zenon lablelling kit for IL-17 (Invitrogen; Z-25304), while the nuclei were counterstained with diamidino-2-phenylindole (DAPI) (BioLegend). Finally, after the sections were coverslipped with fluorescent mounting medium (Dako, Glostrup, Denmark), the fluorescent images were examined with BZ-X710 (Keyence, Osaka, Japan) and analysed for comparison of the intensities of NR4A2.
In-vitro analysis of molecular expression and functions The protocol of each condition was as follows: for Th17-polarizing conditions, anti-CD3 antibody coated previously at a final concentration of 1 lg/ml (R&D Systems, Minneapolis, MN, USA; MAB100), 1 lg/ml of soluble anti-CD28 antibody (R&D, MAB342), 10 IU/ml of human recombinant IL-2 (R&D), 5 ng/ml of human recombinant transforming growth factor (TGF)-b1 (R&D), 12Á5 ng/ml of human recombinant IL-1b (eBioscience), 25 ng/ml of human recombinant IL-6 (eBioscience), 25 ng/ml of human recombinant IL-21 (eBioscience), 25 ng/ml of human recombinant IL-23 (eBioscience), 2 lg/ml of anti-IFN-g antibody (eBioscience; 16-7318-81) and 2 lg/ ml of anti-IL-4 antibody (eBioscience; 16-7048) were used. For Th0 conditions, anti-CD3 antibody coated previously at a final concentration of 1 lg/ml, 1 lg/ml of soluble anti-CD28 antibody, 10 IU/ml of human recombinant IL-2, 2 lg/ml of anti-IFN-g antibody and 2 lg/ml of anti-IL-4 antibody were used. For Th1-polarizing conditions, anti-CD3 antibody coated previously at a final concentration of 1 lg/ml, 1 lg/ml of soluble anti-CD28 antibody, 50 IU/ml of human recombinant IL-2, 80 ng/ml of human recombinant IL-12 (eBioscience) and 4 lg/ml of anti-IL-4 antibody were used for the next experiment as control conditions.
Protein expression and intracellular localization of NR4A2 during Th17 differentiation. Peripheral na€ ıve CD4
1 T cells (CD4 1 CD25 -CD45RA 1 cells) were isolated from PBMCs using MoFlo XDP (Beckman Coulter, Brea, CA, USA), after staining with APC-labelled anti-CD4 antibody (BioLegend; 317416), fluorescein isothiocyanate (FITC)-labelled anti-CD45RA antibody (BioLegend; 304106) and PE-labelled anti-CD25 antibody (BioLegend; 302606). The isolated cells cultured under Th17-polarizing conditions, Th1-polarizing conditions or Th0 conditions, as described above, were smeared on a slide using Smear Gell (Genostaff, Tokyo, Japan) and then fixed and permeabilized with 4% paraformaldehyde/PBS (Wako, Osaka, Japan) at room temperature for 30 min. The slides were stained with rabbit anti-NR4A2 antibody (Santa Cruz; sc-991) (diluted to 1 lg/ml) followed by staining of Alexa Flour 488 goat antirabbit IgG antibody (Invitrogen; A-11034) (diluted to 20 lg/ml) and DAPI, as described above. The exposure time was set to 1/5 s on the observation at 3200 times magnification and 1/15 s at 31000 magnification. The fluorescence intensity of AlexaFluor 488 was quantified using BZ-X analyzer (Keyence). First, the protein expression of NR4A2 in naive CD4 1 T cells of healthy subjects was examined by quantification of the intensity within the entire cells at each time-point during Th17 polarization at 3200 magnification using BZ-X analyser (Keyence). Secondly, intracellular localization of NR4A2 was compared in Th0, Th1 and Th17-polarized CD4 1 T cells differentiated from peripheral naive CD4 1 T cells of healthy subjects. The nuclear expression rate was determined using BX-Z analyser (Keyence) by calculating the ratio of the nuclear fluorescence intensity within DAPIstained area, extracted automatically, to the entire fluorescence intensity in each cell within the field of view at 31000 magnification. We examined intranuclear NR4A2 expression by using DAPI in a similar manner to control nuclear protein in the present study. Thirdly, intracellular localization of NR4A2 in naive CD4 1 T cells cultured under Th0 or Th17-polarizing conditions was compared quantitatively between SS patients (n 5 5) and age-and sex-matched healthy subjects (n 5 3) within the field of view at 31000 magnification using BZ-X analyser (Keyence), as described above.
Inhibition of intranuclear localization of NR4A2 by importazole under Th17 polarization. Importin-b mediates nuclear transport of cargo proteins, including NR4A2, which contains nuclear localization signals (NLS) sequence [15] , by forming a complex with importin-a [22] which can be inhibited by importazole (IPZ), an importin-b inhibitor [23] .
First, we examined the effect of IPZ (Sigma-Aldrich, St Louis, MO, USA) on intranuclear localization of NR4A2 in naive CD4
1 T cells, isolated from PBMCs as described above, cultured under Th0-or Th17-polarizing conditions (n 5 5). IPZ was added at 15 lM during the last 6 h of Th0-or Th17-polarizing conditions, and dimethylsulphoxide (DMSO) was used at the same dose as the control. The cells were collected at day 4 and smeared on slides followed by immunofluorescence staining for NR4A2 as described above or analysed using flow cytometry following intracellular staining for IL-17 and IFN-g as described above. Secondly, the mRNA expression levels of IL-21 and retinoic acid receptor-related orphan receptor C (RORC) in naive CD4 1 T cells (day 4) cultured under Th0 or Th17-polarizing conditions were compared using qPCR following the addition of IPZ (15 lM) or control (DMSO) during the last 6 h of culture.
Statistical analyses
All values are expressed as mean 6 standard deviation, unless stated otherwise. All tests were two-sided, and results were considered significant when P < 0. 
Results
cDNA microarray analysis
In SS patients, 1785 up-regulated probe sets (corresponding to 1320 up-regulated genes) and 1771 down-regulated probe sets (corresponding to 1321 down-regulated genes) were identified as DEGs (FDR < 0Á05, compared with IgG4-RD) (Supporting information, Table S1 ). Geneannotation enrichment analysis by the Web tool DAVID and QuickGO showed that significantly enriched Gene Ontology (GO) terms (FDR-corrected P-value < 0Á0001) found in highly expressed probe sets in SS compared with IgG4-RD included protein glycosylation, immune response, antigen processing and presentation of peptide antigen via major histocompatibility complex (MHC) class I, Golgi vesicle transport, co-translational protein targeting to membrane, endoplasmic reticulum (ER) unfolded protein response and response to virus, as reported previously by our group [7] . In contrast, gene-annotation enrichment analysis by GO annotation showed that the down-regulated set of DEGs in SS encoded proteins that function in wound healing, response to inorganic substance, skeletal system development, muscle organ development, heart development, angiogenesis, cell morphogenesis involved in cDNA microarray identifies NR4A2 in SS differentiation, cell projection organization, muscle contraction, extracellular matrix organization, actin cytoskeleton organization, cell-matrix adhesion, regulation of cell migration, regulation of cell-substrate adhesion, positive regulation of cell adhesion, regulation of cell proliferation, enzyme linked receptor protein signalling pathway, regulation of inflammatory response and translational elongation, as shown in our previous report [7] .
Validation by qPCR
The mean age of the sample donors was 51Á8 6 18Á3 years in the SS group, 60Á5 6 13Á0 years in the IgG4-RD group and 60Á5 6 16Á3 years in the HC group. There were no significant differences among them when they were compared using Kruskal-Wallis test. We extracted the following six DEGs for validation by qPCR, which fulfilled the conditions described in the Methods: chemokine (C-X-C motif) ligand 9 (CXCL9) (rank 4, log FC 5 4Á12), NR4A2 (rank 43, log FC 5 1Á82), CD26 (dipeptidyl peptidase-4, DPP4) (rank 55, log FC 5 1Á50), serum and glucocorticoidregulated kinase 1 (SGK1, rank 93, log FC 5 1Á47), interferon regulatory factor 4 (IRF4, rank 96, log FC 5 1Á55) and phosphoinositide-dependent kinase 1 (PDK1, rank 108, log FC 5 1Á42). We confirmed significantly higher mRNA expression of NR4A2 in LSGs of SS patients than in those of IgG4-RD patients (P < 0Á05). The expression level of IRF4 was also significantly higher in SS patients than in IgG4-RD patients (P <0Á05). The expression levels of CD26, SGK1 and PDK1 were similar between the two groups. While the expression level of CXCL9 was significantly higher in SS patients than in HCs, it was not significantly different between SS patients and IgG4-RD patients (Fig. 1) .
Immunofluorescence staining for analysis of protein production
We focused on NR4A2 because of the statistically significant difference in mRNA expression in LSGs between SS patients and IgG4-RD patients. NR4A2 staining in SS patients was apparent while that in IgG4-RD patients was not observed (Fig. 2) . Therefore, counterstaining for CD3, CD4 and IL-17 was performed for detection of NR4A2-producing cells. NR4A2 staining was observed in CD3 1 cells (Fig. 2a) , CD4 1 cells (Fig. 2b) and IL-17-producing cells (Fig. 2c) , whereas almost never in IL-17-non-producing cells, indicating that NR4A2 was produced mainly by Th17 cells in LSGs of SS patients. In addition, NR4A2 was localized in the nuclei of these cells.
Gene expression of NR4A2 in peripheral CD4
T cells of patients with SS
The mRNA expression level of NR4A2 in CD4
1 T cells isolated from PBMCs of patients with SS (n 5 22) was significantly higher, compared with HCs (n 5 10) (Fig. 3a) .
Th17 differentiation of peripheral CD4 1 T cells in patients with SS
Under Th17-polarizing conditions, the population (%) of IL-17
1 IFN-g -cells within the gate on CD4 1 T cells after culture in patients with SS (n 5 5, 4Á50 6 1Á41%) was significantly higher than in the controls (n 5 3, 2Á18 6 0Á84%), while there was no difference in the population between SS and the control under Th0 conditions (Fig. 3b,c) . Furthermore, there was a significant correlation between NR4A2 mRNA expression at baseline and the proportions of IL-17
1 T cells after culture under Th17-polarizing conditions (Spearman's R 5 0Á87, P < 0Á01) (Fig. 3d) .
Protein expression and intracellular localization of NR4A2 during Th17 differentiation NR4A2 protein expression in naive CD4 1 T cells increased towards day 7 under Th0-and Th17-polarizing conditions, while there was no difference in NR4A2 expression between Th0-and Th17-polarizing conditions at all time-points (Fig. 4a,b) . Furthermore, NR4A2 was localized in nuclei of naive CD4 1 T cells specifically under Th17-polarizing conditions (day 4), while it was observed mainly in the cytoplasm of naive CD4 1 T cells under Th1-polarizing and Th0 conditions (Fig. 4c ). The rate of nuclear expression of NR4A2 in naive CD4 1 T cells was significantly higher under Th17-polarizing conditions (82Á6 6 5Á35%) than under Th0 (37Á6 6 21Á9%) and Th1-polarizing conditions (33Á5 6 5Á96%) (Fig. 4d ). In patients with SS, intranuclear NR4A2 expression in Th17-polarized CD4 1 T cells (98Á1 6 2Á0%) was significantly higher than in the control (85Á1 6 8Á1%), while there was no difference in intranuclear NR4A2 expression under Th0 conditions (40Á5 6 11Á9% and 51Á2 6 12Á6%, respectively) (Fig. 4e,f) .
IPZ inhibits intranuclear localization of NR4A2 in naive CD4 1 T cells
Intranuclear localization of NR4A2 in naive CD4 1 T cells was inhibited significantly with IPZ, specifically under Th17-polarizing conditions (control: 90Á0 6 10Á1%, IPZ: 43Á1 6 15Á1%), while there was no significant difference of intranuclear NR4A2 expression under Th0 conditions (control: 36Á9 6 30Á0%, IPZ: 31Á7 6 21Á0%) (Fig. 5a,b) . Furthermore, the population (%) of IL-17 1 IFN-g -cells within the gate on CD4 1 T cells was suppressed significantly by IPZ, specifically under Th17-polarizing conditions (1Á89 6 0Á24% and 1Á16 6 0Á12%, respectively), while there was no significant difference of that population under Th0 conditions (Fig.  5c,d ). IPZ also inhibited IL-21 mRNA expression significantly in naive CD4 1 T cells under Th17-, but not under Th0-polarizing conditions (Fig. 5e) . Conversely, there was no significant difference in RORC expression in naive CD4 1 T cells under Th0-and Th17-polarizing conditions between IPZ and control (Fig. 5f ).
Discussion
We performed cDNA microarray analysis in LSGs of SS and IgG4-RD patients to identify the genes involved in the pathogenesis of SS, because the genes expressed specifically in SS can be possibly identified by comparing the gene expression in LSGs of SS with those of IgG4-RD, which also show inflammation and lymphocyte infiltration. We showed that the up-regulated sets of DEGs in patients with SS-encoded proteins that function in antigen processing and presentation of peptide antigen in the gene-annotation enrichment analysis, as we have reported previously [7] . Although the selected genes are involved in a plethora of function ranging, we particularly identified several GO terms associated with immunological processes in which the up-regulated DEGs in patients with SS were enriched. It seemed to reflect the characteristics of SS. We selected the up-regulated genes in SS compared with IgG4-RD for the validation analysis because they might contribute to the pathogenesis of SS via the gain-of-function effects and thus could be therapeutic targets in SS. Conversely, we did not select the down-regulated genes in SS compared with IgG4-RD in the present study because they might contribute to the pathogenesis of IgG4-RD via up-regulation, as shown in our previous report [7] . Specifically, we focused on the up-regulated genes associated with T cells that are known to play essential roles in these processes in patients with SS. As CD4 1 T cells infiltrate LSGs in both IgG4-RD and SS patients [1, 6] , DEGs associated with T cells could be upregulated specifically in CD4
1 T cells in LSGs of patients with SS. Here we identified NR4A2, which is known as an orphan nuclear receptor. NR4A2 was extracted as a validated molecule and examined for its involvement in the pathogenesis of SS.
First, we examined NR4A2 expression in CD4 1 T cells in LSGs and peripheral blood of patients with SS. The results showed higher NR4A2 expression in CD4 1 T cells in LSGs in patients with SS compared with those of IgG4-RD. NR4A2 has been reported to be induced by stimulation of T cell receptors (TCR) in CD4 1 T cells [24] . Therefore, up-regulation of NR4A2 in CD4 1 T cells infiltrating LSGs could be due primarily to increased TCR reactivity, especially to the pathogenic autoantigens in patients with SS. In addition, up-regulation of NR4A2 was also observed in peripheral blood CD4 1 T cells of patients with SS. A similar finding was reported in patients with multiple sclerosis (MS) [14] . The model for MS, EAE, also shows up-regulation of NR4A2 in peripheral blood T cells following achieving peak value of NR4A2 expression in T cells infiltrating the central nervous system [13, 14] . This is likely to result from activation of peripheral T cells after peripheral recruitment of antigen-presenting cells (APCs) engulfing myelin, which contains the autoantigens. Therefore, increased NR4A2 expression in peripheral CD4 1 T cells of patients with SS could also be caused by a response to the pathogenic APCs recruited from the inflammatory sites, including salivary glands, to the periphery. On the contrary, there are contrasting reports which showed downregulation of NR4A2 in PBMCs or whole blood samples from patients with MS [25, 26] . However, they are not inconsistent with the above-mentioned reports of MS and our results because the cell populations used for expression analysis of NR4A2 were different. In addition, exacerbation of EAE in heterozygous NR4A2 total knock-out mice was shown in the other report [27] . It seems to contradict the above-mentioned reports of EAE, which suggested the pathogenic role of NR4A2 up-regulation in CD4 1 T cells of EAE mice. However, the other report showed amelioration of acute EAE in CD4-specific NR4A2 conditional knock-out mice, in which NR4A2 was deleted selectively in CD4 1 T cells [28] . Therefore, when the NR4A2 defect is restricted to CD4 1 T cells in EAE mice, its pathogenic role in CD4 1 T cells could become clear. Secondly, we examined the association of NR4A2 expression with Th17 cells using LSGs and peripheral blood of patients with SS. The results of immunofluorescence staining suggested the production of NR4A2 in Th17 cells, and this production was specific to SS. The molecular function of NR4A2 might be involved in local accumulation and activation of Th17 cells in the salivary glands of patients with SS. Furthermore, in patients with SS, peripheral CD4 1 T cells preferentially differentiated into Th17 cells under Th17-polarizing conditions, compared with the controls. In addition, the positive correlation between NR4A2 expression at baseline and the degree of Th17 cell development suggests that increased polarization into Th17 cells was due in part to higher NR4A2 expression in patients with SS. Thirdly, we examined the role of intracellular localization of NR4A2 in Th17 cell development. NR4A2 was localized in the nuclei of CD4 1 T cells specifically under Th17-polarizing conditions, while it was in the cytoplasm under Th0 and Th1-polarizing conditions. These results suggest that NR4A2 translocates to the nuclei and functions as a transcriptional factor in CD4 1 T cells under Th17-polarizing conditions. The intracellular localization of NR4A2 in cancer cells was also examined in another report [29] . While NR4A2 suppresses bladder cancer growth when transactivated [30] , the cytoplasmic expression of NR4A2 in bladder tumors correlates with tumour progression [29] . However, there have been no reports which show the intracellular localization of NR4A2 in T cells. NR4A2 was reported to contain both NLS and nuclear export signals (NES) within its protein [15] . The NLS is bound to importin-a and forms a complex with importin-a/b1, which mediates nuclear transport of cargo proteins, while the NES is bound to exportin and forms a complex with exportin, which mediates nuclear export of cargo proteins [19] . It is possible that intracellular localization depends on a balance between the importin signal and the exportin signal. In this context, under Th17-polarizing conditions, intranuclear localization of NR4A2 in CD4 1 T cells could be determined by the dominance of the importin signal. We also examined the role of nuclear transport of NR4A2 in CD4 1 T cells on Th17 cell development by inhibiting nuclear transport of NR4A2 using IPZ. IPZ clearly inhibited Th17 cell development and IL-21 expression under Th17-polarizing conditions. As no functional NLS was determined in the already-known Th17-related molecules, including RORg, STAT-3, IRF-4 and c-maf, and other transcription factors related to other helper T cell subsets and regulatory T cells, including T-bet, GATA binding protein 3 (GATA-3), B cell lymphoma 6 (Bcl6) and forkhead box protein 3 (FoxP3), using cNLS Mapper (data not shown) [31] , IPZ seems to have a selective effect on nuclear transport of NR4A2, at least under Th17-polarizing conditions. Therefore, this result suggests that nuclear transport of NR4A2 is involved in Th17 cell development through the promotion of IL-21 expression. As far as we searched, there was neither report nor evidence which showed that IL-21 had Nur-response element (NurRE) or NGFI-B response element (NBRE). However, it was shown that NR4A2 knock-down by siRNA blocked c-maf up-regulation, a transcription factor reported to control IL-21 expression in Th17 development [13] . Therefore, it is possible that such indirect pathways between NR4A2 and IL-21 exist.
In addition, the primary roles of IL-21 in Th17 cell development include expansion and stabilization of existing Th17 cells [32] . Evidence suggests the presence of IL-21 signalling pathway in Th17 that is independent of RORgt [33] . We performed the analysis of the mRNA expression level of RORC in the presence of IPZ under Th17-polarizing conditions in order to explore whether inhibition of nuclear translocation of NR4A2 by IPZ could suppress the Th17 master transcriptional factor, RORgt, which is encoded by RORC. The lack of effect of IPZ on RORC in our study suggests that NR4A2 is likely to be involved in the regulation of IL-21 expression in Th17 cells independently of RORgt.
Fourthly, we examined the intracellular localization of NR4A2 in SS. We observed increased nuclear expression of NR4A2 in Th17-polarized peripheral CD4
1 T cells as well as CD4
1 T cells infiltrating LSGs in patients with SS. This is partially because increased NR4A2 expression in CD4 1 T cells could enhance Th17-polarizing cytokine environment via Th17 cell expansion, which consequently accelerates further the importin signal and intranuclear localization of NR4A2 in patients with SS.
In summary, NR4A2 is induced by TCR stimulation and localized in the nuclei of CD4 1 T cells by Th17-polarizing cytokine environment. Moreover, intranuclear localization of NR4A2 in CD4 1 T cells could be involved in Th17 cell development via IL-21 expression independently of RORgt. Increased expression and intranuclear localization of NR4A2 in CD4
1 T cells could contribute to increased Th17 cell development in patients with SS (Fig. 6) .
The central nervous system involvement in patients with SS often resembles MS and the clinical presentations in these conditions overlap each other at least in some patients [34, 35] . Therefore, over-expression of NR4A2 in T cells might possibly explain the common pathology which is shared by SS and MS. As NR4A2 siRNA knock-down in CD4 1 T cells prevented and treated the pathological conditions of EAE [13] , NR4A2 is a potential target molecule in the treatment of SS. Among NR4A2-targeted therapeutic strategies, inhibition of the importin signal in CD4 1 T cells by IPZ could also be a hopeful approach to treatment for SS. However, further studies using mouse models of SS are needed to elucidate the in-vivo effects of IPZ.
In conclusion, our results suggest that NR4A2 could play a role in the pathogenesis of SS through the promotion of Th17 cell development due to up-regulation and increased nuclear localization of NR4A2. To our knowledge, this is the first report to demonstrate the potential role of NR4A2 in the pathogenesis of SS.
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